Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Notes underwriting agrmnt
|
|
GELESIS HOLDINGS, INC. (CSPR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 09/29/2023 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials: |
| 08/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/25/2023 |
SC 13E3
| Form SC 13E3 - Going private transaction by certain issuers: |
| 07/24/2023 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 07/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/30/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/29/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 06/29/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 06/13/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"AGREEMENT AND PLAN OF MERGER by and among PURETECH HEALTH LLC, CAVIAR MERGER SUB LLC and GELESIS HOLDINGS, INC. Dated as of June 12, 2023",
"VOTING AND SUPPORT AGREEMENT This Voting and Support Agreement is made and entered into as of June 12, 2023, by and between Gelesis Holdings, Inc., a Delaware corporation and each of the persons set forth on Schedule Ahereto . The Company and the Stockholders are each sometimes referred to herein as a “Party” and collectively as the “Parties”. RECITALS WHEREAS, concurrently with the execution hereof, PureTech Health LLC, a Delaware limited liability company , Caviar Merger Sub LLC, a Delaware limited liability company and a wholly owned Subsidiary of Parent , and the Company are entering into an Agreement and Plan of Merger , pursuant to which the Company will be merged with and into Merger Sub, with Merger Sub continuing as the surviving company and a wholly ow...",
"AMENDMENT NO. 2 TO",
"CONVERTIBLE SENIOR SECURED PROMISSORY NOTE Note No. 4 June 12, 2023 $3,000,000 FOR VALUE RECEIVED, Gelesis Holdings, Inc. a Delaware corporation and Gelesis, Inc., a Delaware corporation , hereby promises to pay to the order of PureTech Health LLC as nominee , the principal sum of THREE MILLION DOLLARS , together with interest, which shall accrue at a rate of twelve percent per annum, compounded annually, on the Maturity Date. This Note is one of a series of Notes issued pursuant to that certain Note and Warrant Purchase Agreement, dated February 21, 2023 and amended on May 1, 2023 and June 12, 2023, by and among the Company, the Co-Issuer, the Guarantors, and the Investors named therein . Capitalized terms not defined herein shall have the meaning set forth in the Purchase Agreement. 1. P..." |
|
| 05/31/2023 |
4
| PureTech Health plc (10% Owner) has filed a Form 4 on GELESIS HOLDINGS, INC.|
Txns:
| Bought convertible notes
@ $0.0142, valued at
$0
Bought 43,133,803 warrants
@ $0.0142, valued at
$612.5k
|
|
| 05/31/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"LIMITED WAIVER TO",
"CONVERTIBLE SENIOR SECURED PROMISSORY NOTE Note No. 3 May 26, 2023 $350,000 FOR VALUE RECEIVED, Gelesis Holdings, Inc. a Delaware corporation and Gelesis, Inc., a Delaware corporation , hereby promises to pay to the order of PureTech Health LLC as nominee , the principal sum of THREE HUNDRED FIFTY THOUSAND DOLLARS , together with interest, which shall accrue at a rate of twelve percent per annum, compounded annually, on the Maturity Date. This Note is one of a series of Notes issued pursuant to that certain Note and Warrant Purchase Agreement, dated February 21, 2023 and amended on May 1, 2023, by and among the Company, the Co-Issuer, the Guarantors, and the Investors named therein . Capitalized terms not defined herein shall have the meaning set forth in the Purchase Agreement. 1. Payment...",
"WARRANT TO PURCHASE COMMON STOCK OF GELESIS HOLDINGS, INC. Warrant No. 3 Gelesis Holdings, Inc., a Delaware corporation , hereby certifies that, for value received and pursuant to the Note and Warrant Purchase Agreement, dated as of and amended as of May 1, 2023, by and among the Company and the Investors named therein , PureTech Health LLC , is entitled, subject to the terms and conditions set forth in this warrant , to purchase from the Company, at any time or times on or after the date hereof, but not after 5:00 P.M., New York City time on May 26, 2028 , 43,133,803 duly authorized, validly issued, fully paid, nonassessable shares of Common Stock , which shall be adjusted or readjusted from time to time as provided in this Warrant , at a purchase price per share equal to $0.0142, which s..." |
|
| 05/30/2023 |
SC 13D/A
| PureTech Health LLC reports a 88.4% stake in Gelesis Holdings, Inc. |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
SC 13D/A
| PureTech Health LLC reports a 87% stake in Gelesis Holdings, Inc. |
| 04/26/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/21/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/17/2023 |
8-K
| Quarterly results |
| 04/04/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 04/04/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 03/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/31/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/28/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/03/2023 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Interactive Data |
| 03/02/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 02/23/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 02/23/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"GELESIS HOLDINGS, INC.   GELESIS, INC.   AND THE GUARANTORS PARTY HERETO FROM TIME TO TIME   NOTE AND WARRANT PURCHASE AGREEMENT           1. Definitions 1 2. Amount and Terms of the Secured Senior Notes 7   2.1 Issuance of Initial Investor Notes 7   2.2 Issuance of Additional Investor Notes 7   2.3 Issuance of Other Investor Notes 8   2.4 Several Obligations; Maximum Principal Amount 8   2.5 Maturity 8   2.6 Interest; Interest Rate; Interest Payment Date 8   2.7 Payments 9   2.8 Security 9   2.9 Priority 9   2.10 Holder Conversion of Notes 9   2.11 Company Conversion of Notes 10   2.12 Delivery of Conversion Shares 10   2.13 No Fractional Shares; Surren...",
"CONVERTIBLE SENIOR SECURED PROMISSORY NOTE Note No. [__] [Date of Issuance] $ FOR VALUE RECEIVED, Gelesis Holdings, Inc. a Delaware corporation and Gelesis, Inc., a Delaware corporation , hereby promises to pay to the order of [______________] as nominee , the principal sum of [______________] DOLLARS , together with interest, which shall accrue at a rate of twelve percent per annum, compounded annually, on the Maturity Date. This Note is one of a series of Notes issued pursuant to that certain Note and Warrant Purchase Agreement, dated February 21, 2023, by and among the Company, the Co-Issuer, the Guarantors, and the Investors named therein . Capitalized terms not defined herein shall have the meaning set forth in the Purchase Agreement. 1.       ...",
"WARRANT TO PURCHASE COMMON STOCK OF GELESIS HOLDINGS, INC.   Warrant No. [___] [Date]   Gelesis Holdings, Inc., a Delaware corporation , hereby certifies that, for value received and pursuant to the Note and Warrant Purchase Agreement, dated as of February [__], 2023, by and among the Company and the Investors named therein , [Name of Holder] , is entitled, subject to the terms and conditions set forth in this warrant , to purchase from the Company, at any time or times on or after the Stockholder Approval Date, but not after 5:00 P.M., New York City time on the fifth anniversary of the Stockholder Approval Date , [_______] 1 duly authorized, validly issued, fully paid, nonassessable shares of Common Stock , which shall be adjusted or readjusted from tim...",
"SECURITY AND PLEDGE AGREEMENT",
"PATENT SECURITY AGREEMENT This PATENT SECURITY AGREEMENT is made this 21 day of February, 2023, by and among the Grantors listed on the signature pages hereof , and PureTech Health LLC, a Delaware limited liability company and as Secured Party for all of the Holders . WITNESSETH: WHEREAS, pursuant to that certain Note and Warrant Purchase Agreement, dated as of February 21, 2023, by and among Gelesis Holdings, Inc., a Delaware corporation , Gelesis, Inc., a Delaware corporation , the Initial Holder, and such additional holders from party thereto from time to time , the Company and the Co-Issuer, have issued to the Holders the 12.0% Convertible Senior Secured Notes due 2023 . Each Grantor is entering into this Patent Security Agreement in order to induce the Holders to purchase the Notes an...",
"TRADEMARK SECURITY AGREEMENT   This TRADEMARK SECURITY AGREEMENT is made this 21 day of February, 2023, by and among the Grantors listed on the signature pages hereof , and PureTech Health LLC, a Delaware limited liability company and as Secured Party for all of the Holders .   WITNESSETH:   WHEREAS, pursuant to that certain Note and Warrant Purchase Agreement, dated as of February 21, 2023, by and among Gelesis Holdings, Inc., a Delaware corporation , Gelesis, Inc., a Delaware corporation , the Initial Holder, and such additional holders from party thereto from time to time , the Company and the Co-Issuer, have issued to the Holders the 12.0% Convertible Senior Secured Notes due 2023 . Each Grantor is entering into this Trademark Security Agreemen..." |
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|